Agnes Shanley
Advertisement
Agnes Shanley is senior editor of BioPharm International.
Articles by Agnes Shanley
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
FDA Clears In-Vivo Gene Editing Therapy PBGENE-DMD for Duchenne Trial
2
The Clinical Execution Gap: Why Great Science Often Fails at the Trial Stage
3
VectorY Doses First Patient in TDP-43–Targeting ALS Trial
4
Preclinical Study Finds Subcutaneous Nanotrastuzumab Comparable to Herceptin HYLECTA in Minipig Model
5